PSI VisSIG Wonderful Wednesday Webinar Series
This is a good opportunity to develop your knowledge by thinking through a practical example, practicing how to apply graphics principles, and developing your coding skills.
Core Committee (L-R): Fetene Tekle (Janssen), Gareth Thomas (former member and chair), Bernd Igl (Boehringer Ingelheim), Eloisa Brook (chair, GlaxoSmithKline), Jim Saul (Covance) and Phillip Jarvis (Novartis). Luc Essermeant (Sanofi) and Ezgi Tanriver-Ayder (GlaxoSmithKline) have also recently joined the team.
To provide a forum to discuss and advance statistical topics related to Research, Discovery (including efficacy models), Regulatory and Investigative Toxicology/Safety Assessment and to promote the involvement of Statisticians in these areas.
Our membership consists of statisticians at CROs, pharmaceutical companies and academia who are working in areas such as:
- Discovery
- Good statistical practice in in-vitro, ex-vivo and in-vivo assay development
- Reproducibility and Translation from pre-clinical to clinical
- Toxicogenomics
- Genetic Toxicology
- Acute Toxicology
- General Toxicology
- Eco-Toxicology
- Toxicokinetics
- DMPK / Pharmacokinetics
- ECG
- Immuno Toxicology
- Histopathology
- Pharmacology
- Developmental and Reproductive Toxicology
- Carcinogenicity
We discuss diverse topics ranging from Dog Telemetry data analysis to Decision Trees, from Bayesian methods to dealing with irate study directors, and now have a list of over 50 affiliates on our e-mail distribution list.
Find out more in our video overview:
The PSI Pre-clinical Special Interest Group have a series of regular FREE webinars dealing with statistical topics faced in pre-clinical and related fields. The presentations will run for an hour, with approximately 45 min presentation and a Q&A session in the remaining time. See section below for details of this year’s webinars.
PSI Pre-Clinical workshop is back! This year it will be run virtually, including a training course on Bayesian Statistics for Preclinical Research: New Opportunities.
The workshop will be on Wednesday 21st September and Thursday 22nd September 2022 with a training course given by Bruno Boulanger and Brad Carlin from PharmaLex along with presentations on applications of Bayesian methodology given by Marie Miossec from IT&M stat focusing on Bayesian tumor volume analysis with BRMS R package and Helena Geys from Janssen focusing on Bayesian Generalized Frailty Model for Comet Assays.
Key topics covered by the course include:
Please note that this event will take place online via Zoom, and has a limited number of places available. For more information and to register for this workshop, please follow this link: PSI Pre-Clinical SIG Workshop 2022 (psiweb.org)
We are planning to hold our 10th and first fully virtual 1.5 day workshop on 21/22 September, 2022.
Date | Title | Presenter | |
21/22 Sept | Workshop including a training course and presentations on the application of Bayesian Methods in Preclinical Environment | Bruno Boulanger, PharmaLex Bradley Carlin, PharmaLex Marie Miossec, IT&M Stats Helena Geys, Janssen | For more information and to register please click here |
The PSI Pre-Clinical Special Interest Group seminars for 2022 are as follows:
Date | Title | Presenter | |
12 April | Optimal Experimental Design in Preclinical Dose Response Studies | Dr. Tim Holland-Letz, DKFZ | To access the video on demand, please click here |
21 June | Regression to the mean, dilution and bridging studies illustrated in R | Dr. Bernard Francq, GSK | To access the video on demand, please click here |
4 October | Therioepistemology: Rethinking how we conduct animal-based experimentation | Dr. Brianna Gaskill, Novartis | More information pending |
For all previous webinars click here.
Please email us with any questions or comments and if you would like to join our mailing list.